Skip to main content
Addex Therapeutics Ltd (SWX:ADXN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
0.0646
+0.0022 (3.53%)
Mar 3, 2025, 5:31 PM CET

Addex Therapeutics Revenue

Addex Therapeutics had revenue of 58.35K CHF in the quarter ending September 30, 2024, a decrease of -82.28%. This brings the company's revenue in the last twelve months to 592.36K, down -71.27% year-over-year. In the year 2023, Addex Therapeutics had annual revenue of 1.65M with 13.99% growth.

Revenue (ttm)
592.36K
Revenue Growth
-71.27%
P/S Ratio
10.37
Revenue / Employee
25.75K
Employees
23
Market Cap
6.35M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.65M202.11K13.99%
Dec 31, 20221.44M-1.71M-54.18%
Dec 31, 20213.15M-725.84K-18.71%
Dec 31, 20203.88M1.05M36.89%
Dec 31, 20192.83M-3.87M-57.72%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Roche Holding AG 62.40B
Novartis AG 46.87B
Alcon 8.98B
Lonza Group AG 6.57B
Galderma Group AG 3.88B
Straumann Holding AG 2.50B
Sandoz Group AG 9.09B
Sonova Holding AG 3.71B
Revenue Rankings

Addex Therapeutics News

More News